Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 102

1.

The effect of time from biopsy to radical prostatectomy on adverse pathologic outcomes.

Patel P, Sun R, Shiff B, Trpkov K, Gotto GT.

Res Rep Urol. 2019 Mar 6;11:53-60. doi: 10.2147/RRU.S187950. eCollection 2019.

2.

Extraprostatic Extension Is Extremely Rare for Contemporary Gleason Score 6 Prostate Cancer.

Anderson BB, Oberlin DT, Razmaria AA, Choy B, Zagaja GP, Shalhav AL, Meeks JJ, Yang XJ, Paner GP, Eggener SE.

Eur Urol. 2017 Sep;72(3):455-460. doi: 10.1016/j.eururo.2016.11.028. Epub 2016 Dec 13.

PMID:
27986368
3.

Evaluating the impact of length of time from diagnosis to surgery in patients with unfavourable intermediate-risk to very-high-risk clinically localised prostate cancer.

Gupta N, Bivalacqua TJ, Han M, Gorin MA, Challacombe BJ, Partin AW, Mamawala MK.

BJU Int. 2018 Dec 20. doi: 10.1111/bju.14659. [Epub ahead of print]

PMID:
30570825
4.

Prognostic significance and biopsy characteristics of prostate cancer with seminal vesicle invasion on radical prostatectomy: a nationwide population-based study.

Kristiansen A, Drevin L, Delahunt B, Samaratunga H, Robinson D, Franck Lissbrant I, Stattin P, Egevad L.

Pathology. 2017 Dec;49(7):715-720. doi: 10.1016/j.pathol.2017.08.008. Epub 2017 Oct 14.

PMID:
29037803
5.

Delay from biopsy to radical prostatectomy influences the rate of adverse pathologic outcomes.

Berg WT, Danzig MR, Pak JS, Korets R, RoyChoudhury A, Hruby G, Benson MC, McKiernan JM, Badani KK.

Prostate. 2015 Jul 1;75(10):1085-91. doi: 10.1002/pros.22992. Epub 2015 Mar 21.

PMID:
25809289
6.

Prostate biopsy perineural invasion is not independently associated with positive surgical margins following radical retropubic prostatectomy.

Ristau BT, Tomaszewski JJ, Chen YF, Bertolet M, Woldemichael E, Nelson JB.

World J Urol. 2015 Sep;33(9):1269-74. doi: 10.1007/s00345-014-1430-2. Epub 2014 Nov 1.

PMID:
25366883
7.

Correlation of margin status and extraprostatic extension with progression of prostate carcinoma.

Cheng L, Darson MF, Bergstralh EJ, Slezak J, Myers RP, Bostwick DG.

Cancer. 1999 Nov 1;86(9):1775-82.

PMID:
10547551
9.

Outcome after radical prostatectomy with a pretreatment prostate biopsy Gleason score of >/=8.

Manoharan M, Bird VG, Kim SS, Civantos F, Soloway MS.

BJU Int. 2003 Oct;92(6):539-44.

11.

The significance of microscopic bladder neck invasion in radical prostatectomies: pT4 disease?

Ruano T, Meirelles L, Freitas LL, Magna LA, Ferreira U, Billis A.

Int Urol Nephrol. 2009;41(1):71-6. doi: 10.1007/s11255-008-9400-5. Epub 2008 Jun 19.

PMID:
18563619
12.

Tertiary Gleason pattern in radical prostatectomy specimens is associated with worse outcomes than the next higher Gleason score group in localized prostate cancer.

Özsoy M, D'Andrea D, Moschini M, Foerster B, Abufaraj M, Mathieu R, Briganti A, Karakiewicz PI, Roupret M, Seitz C, Czech AK, Susani M, Shariat SF.

Urol Oncol. 2018 Apr;36(4):158.e1-158.e6. doi: 10.1016/j.urolonc.2017.12.003. Epub 2017 Dec 27.

PMID:
29288003
13.

Index tumor volume on MRI as a predictor of clinical and pathologic outcomes following radical prostatectomy.

Sugano D, Sidana A, Jain AL, Calio B, Gaur S, Maruf M, Merino M, Choyke P, Turkbey B, Wood BJ, Pinto PA.

Int Urol Nephrol. 2019 May 16. doi: 10.1007/s11255-019-02168-4. [Epub ahead of print]

PMID:
31098818
14.

Extraprostatic Extension in Core Biopsies Epitomizes High-risk but Locally Treatable Prostate Cancer.

Goldberg H, Ramiz AH, Glicksman R, Salgado NS, Chandrasekar T, Klaassen Z, Wallis CJD, Hosni A, Moraes FY, Ghai S, Kulkarni GS, Hamilton RJ, Perlis N, Toi A, Chung P, Evans A, van der Kwast T, Finelli A, Fleshner N, Berlin A.

Eur Urol Oncol. 2019 Feb;2(1):88-96. doi: 10.1016/j.euo.2018.05.003. Epub 2018 May 27.

PMID:
30929849
15.

Impact of capsular incision on biochemical recurrence after radical perineal prostatectomy.

Kwak KW, Lee HM, Choi HY.

Prostate Cancer Prostatic Dis. 2010 Mar;13(1):28-33. doi: 10.1038/pcan.2009.19. Epub 2009 Jun 2.

16.

Clinical and pathological significance of the level and extent of capsular invasion in clinical stage T1-2 prostate cancer.

Wheeler TM, Dillioglugil O, Kattan MW, Arakawa A, Soh S, Suyama K, Ohori M, Scardino PT.

Hum Pathol. 1998 Aug;29(8):856-62.

PMID:
9712429
17.

Clinical and pathologic predictors of Gleason sum upgrading in patients after radical prostatectomy: results from a single institution series.

Tilki D, Schlenker B, John M, Buchner A, Stanislaus P, Gratzke C, Karl A, Tan GY, Ergün S, Tewari AK, Stief CG, Seitz M, Reich O.

Urol Oncol. 2011 Sep-Oct;29(5):508-14. doi: 10.1016/j.urolonc.2009.07.003. Epub 2009 Oct 17.

PMID:
19837614
18.

Lymph node yield during radical prostatectomy does not impact rate of biochemical recurrence in patients with seminal vesicle invasion and node-negative disease.

Badani KK, Reddy BN, Moskowitz EJ, Paulucci DJ, Beksac AT, Martini A, Whalen MJ, Skarecky DW, Huynh LM, Ahlering TE.

Urol Oncol. 2018 Jun;36(6):310.e1-310.e6. doi: 10.1016/j.urolonc.2018.03.004. Epub 2018 Apr 4.

PMID:
29625782
19.

Grade Groups Provide Improved Predictions of Pathological and Early Oncologic Outcomes Compared with Gleason Score Risk Groups.

Kirmiz S, Qi J, Babitz SK, Linsell S, Denton B, Singh K, Auffenberg G, Montie JE, Lane BR.

J Urol. 2019 Feb;201(2):278-283. doi: 10.1016/j.juro.2018.08.081.

PMID:
30195846
20.

More Favorable Pathological Outcomes in Men with Low Risk Prostate Cancer Diagnosed on Repeat versus Initial Transrectal Ultrasound Guided Prostate Biopsy.

ElShafei A, Nyame Y, Kara O, Badawy A, Amujiogu I, Fareed K, Klein E, Jones JS.

J Urol. 2016 Jun;195(6):1767-72. doi: 10.1016/j.juro.2015.12.079. Epub 2015 Dec 24.

PMID:
26724397

Supplemental Content

Support Center